Israeli Marijuana is growing, but exports have nowhere to go

With dozens of Israeli growers and manufacturers receiving licenses to produce medicinal cannabis, bureaucratic roadblocks and ministerial infighting could leave the marijuana to eventually rot or be sold on the black market, costing companies more than NIS 1 billion.

Last week, the cabinet hinted that it would approve exports of medicinal cannabis during the 2019 state budget vote, only to dash hopes by leaving the measure out.

The government reportedly told Israeli medicinal marijuana companies that their exports would be approved by 2018, according to industry employees. That persuaded the companies to embark on multi-billion shekel investments, some of which could now be in jeopardy.


Cannabis research may yield new diet drug, Israeli researcher says

While cannabis science in the U.S. remains heavily politicized and mired in red tape, our international ally, Israel, is racing ahead.

On Tuesday, Jan. 16 at 6 p.m., The California Israel Chamber of Commerce, American Friends of Hebrew University, and financial advisors WGD Partners host a V.I.P. cocktail reception and discussion with Dr. Yossi Tam, Director of Cannabinoid Research at the Multidisciplinary Center on Cannabinoid Research at the Hebrew University of Jerusalem.

The center, established in 2016 to foster research collaboration, includes 30 different scientists working on cannabis research projects.


Medical cannabis meets insomnia and cryptocurrency

SciCann enters partnership with Global Cannabis Applications Corp., and iCAN-Israel Cannabis teams with Aura Medical to deliver insomnia formulation.

Israel’s role as a leader in the research and development of medical cannabis products was given another boost last week when Israeli-Canadian cannabis startup SciCann Therapeutics entered into a strategic partnership with Global Cannabis Applications Corp. (GCAC) of Vancouver, Canada.

SciCann will develop the drugs while GCAC will qualify trial candidates and analyze the resulting data using a variety of clinical research tools, including artificial intelligence and blockchain.


Israeli farmers catch cannabis fever

Nearly 400 farmers in Israel have applied for licenses to grow cannabis since the government loosened restrictions on medical marijuana last year, according to officials from the Israeli Ministry of Health who provided an update to lawmakers at an Israeli parliamentary committee session Monday.

In addition to the 383 farmers who applied, the ministry has received 250 applications from nurseries wishing to distribute marijuana plants, 95 from pharmacies looking to sell cannabis products, and 60 from entrepreneurs interested in opening marijuana processing facilities. Regulators are reviewing the requests and have already provided preliminary approval to a majority of applicants.


Queensland Bauxite’s subsidiary signs deal for cannabis-based pain relief pill

Queensland Bauxite’s (ASX: QBL) 55%-owned subsidiary Medical Cannabis has inked a contract to establish a joint venture with a group of United States chemists who’ve put together a cannabis-based pain relief pill, in what Queensland Bauxite dubs a “world first” for the medical cannabis sector.

Medical Cannabis signed the letter of intent with the Israeli-recommended group, which has created and manufactured a sample range of GMP quality pain relief pills derived from the cannabis plant.

For an initial A$1 million investment, Medical Cannabis will be able to test and exclusively market the pills, which can offer short and extended pain relief, within Australasia.


Israeli pharmacies set to start selling medical marijuana early next year

Israeli pharmacies nationwide are expected to supply medical marijuana to patients from early 2018, Health Ministry officials said on Wednesday.

The officials said numerous private pharmacies, including Super-Pharm chain pharmacies, have asked the ministry to sell prescription marijuana, and are in the process of being issued the required permits. The health maintenance organization (kupat holim) pharmacies have so far not shown an interest in taking part in the move.


Israel wants to start exporting its cannabis around the world

When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked.

“He was so totally out of it,” said his mother, Ricky Naim Blumenfeld. “It was scary.”

Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital. After a period of trial and error, he started getting a dosage of cannabinoid drops that worked. Four years later, Asi loves music, being at parties, going to the movies and traveling abroad.


Cannabis inhaler could help send Brits suffering with insomnia to sleep in ten minutes

Puffing on a cannabis inhaler could help millions of Brits with insomnia nap off in minutes.

The new hand-held tool squirts a tiny sip of the drug into the lungs.

One smoke of a cannabis inhaler can help insomniacs tumble asleep in as little as 10 minutes

Tests show a singular toke at bedtime can trigger nap in as little as 10 minutes.

Researchers found users nap deeply and arise up rested with no upsetting side-effects.

Medics who invented the inhaler contend it contains adequate of the unlawful drug to have a opiate outcome – but getting users high.

The ICANsleep device – which resembles an asthma puffer – costs around £100.

Research found that users of the ICANsleep device slept deeply but woke up with no upsetting grogginess


Medical cannabis course in high demand at Israeli college

Within the cannabis industry, it’s well known that Israel is leading the world in medical marijuana research. The tiny country is home to a fully legal medical cannabis program that serves 30,000 patients, while THC itself — the cannabis plant’s main psychoactive compound — was discovered by renowned Israeli chemist Raphael Mechoulam in the early sixties. Unlike in the United States, where weed remains illegal under federal law (despite state policies), in Israel, the government sanctions growers, scientists, techies, and doctors to collaborate and advance cannabis medicine.

And so, despite that cannabis for recreational purposes remains illegal in Israel, the plant is well-respected within the fields of science, medicine, biotech, agriculture — and even academia.


US Law firm helping cannabis companies tap into Israel

With legalization for medical use and also in some states recreational use, the cannabis industry has grown precipitously in the United States in recent years. To keep up, a new area of legal practice is growing up to provide services to companies with needs ranging from navigating regulatory hurdles to assisting with finance issues.


Subscribe to RSS - Israel